MASS GENERAL BRIGHAM VENTURES, LLC
MASS GENERAL BRIGHAM VENTURES, LLC is a Seed, Series A and early-stage fund in the US investing in Healthcare, therapeutics, diagnostics, devices and tools.
- Stages
- Seed, Series A, early-stage
- Sectors
- Healthcare, therapeutics, diagnostics, devices, tools
- Invests in
- US-wide
- Founded
- 2008
- Assets under management
- $450M
Check size not disclosed
Thesis
Mass General Brigham Ventures focuses on early-stage life science companies, investing in next-generation companies based on intellectual property from its research community. The firm targets therapeutics, digital health, diagnostics, devices, and tools, supporting companies working on better care delivery and research insights. With a preference for seed and Series A stages, the firm leads Mass General Brigham's translational acceleration platform. Geographically focused on the United States, the firm seeks strong co-investor syndicates and leverages a preferred position to source technology, including first access and rights to disruptive deal flow.
Common questions
Does MASS GENERAL BRIGHAM VENTURES, LLC invest at the Seed stage?
Yes. MASS GENERAL BRIGHAM VENTURES, LLC lists Seed, Series A and early-stage among the stages it invests in.
Where does MASS GENERAL BRIGHAM VENTURES, LLC invest?
MASS GENERAL BRIGHAM VENTURES, LLC invests in the US.